DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Ciraparantag is an investigational drug.
There have been 4 clinical trials for Ciraparantag. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2020.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc., Perosphere, Inc., and [disabled in preview].
There are ten US patents protecting this investigational drug and ninety-three international patents.
Recent Clinical Trials for Ciraparantag
|Study of Ciraparantag for Reversal of Anticoagulation Induced by Apixaban or Rivaroxaban in Healthy Adults||Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.||Phase 2|
|Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT||Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc.||Phase 2|
|Phase 2 Study of Apixaban Reversal by Ciraparantag as Measured by WBCT||Perosphere, Inc.||Phase 2|
Top disease conditions for Ciraparantag
Top clinical trial sponsors for Ciraparantag
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Ciraparantag||⤷ Try it Free||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||⤷ Try it Free|
|Ciraparantag||⤷ Try it Free||Oral drug dosage forms having desired drug release profiles and uses thereof||Triastek, Inc. (Nanjing, CN)||⤷ Try it Free|
|Ciraparantag||⤷ Try it Free||Compartmented pharmaceutical dosage forms||Triastek, Inc. (Nanjing, CN)||⤷ Try it Free|
|Ciraparantag||⤷ Try it Free||Ruthenium-sphingomyelin complexes and methods for their use in the treatment of tumors||⤷ Try it Free|
|Ciraparantag||⤷ Try it Free||Microfluidic chip-based, universal coagulation assay||Perosphere Technologies Inc. (Danbury, CT)||⤷ Try it Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Ciraparantag||Australia||AU2017261372||2036-05-05||⤷ Try it Free|
|Ciraparantag||Canada||CA3023278||2036-05-05||⤷ Try it Free|
|Ciraparantag||China||CN107847398||2036-05-05||⤷ Try it Free|
|Ciraparantag||European Patent Office||EP3452003||2036-05-05||⤷ Try it Free|
|Ciraparantag||Hong Kong||HK1249728||2036-05-05||⤷ Try it Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|